| Filed On | Filing |
|---|---|
| 18 Jun 2025 |
Form 3: Vasconcelles Michael, Head of Research and Dev.
No securities owned |
| 28 Feb 2025 |
Form 3: Merendino Lauren, Chief Commercial Officer
Holds 28,552 shares of Common Stock |
| 19 Jan 2024 |
Form 3: Grossman William, Director
No securities owned |
| 19 Jan 2024 |
Form 3: Dable Habib J, Director
No securities owned |
| 16 Nov 2023 |
Form 3: Dubow Adam, General Counsel
Holds 3,141 shares of Common Stock |
| 14 Sep 2022 |
Form 3: Nicholson Garry A, Director
Holds 0 shares of No securities beneficially owned. |
| 18 Aug 2021 |
Form 3: Garland J. Scott, Director
Holds 0 shares of No securities beneficially owned. |
| 26 May 2021 | Form 3: Atlas Venture Fund XI, L.p., 10% owner and 5 others |
| 26 May 2021 |
Form 3: Grant Papanek Julie, Chair of the Board
Holds 465,000 shares of Common Stock |
| 26 May 2021 |
Form 3: Ramasastry Saira, Director
Holds 50,485 shares of Common Stock |
| 26 May 2021 |
Form 3: Josey John A., Director
Holds 65,292 shares of Common Stock |
| 26 May 2021 |
Form 3: Holles Natalie C., Director
Holds 57,310 shares of Common Stock |
| 26 May 2021 | Form 3: Gladstone Michael, Director |
| 26 May 2021 | Form 3: Becker Daniel J., Director |
| 26 May 2021 |
Form 3: Blackman Samuel C., Chief Medical Officer
Holds 2,386,718 shares of Common Stock |
| 26 May 2021 |
Form 3: York Charles N Ii, COO, CFO and Secretary
Holds 337,560 shares of Common Stock |
| 26 May 2021 |
Form 3: Bender Jeremy, Director
Holds 1,828,838 shares of Common Stock |
| 26 May 2021 |
Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other
Holds 6,470,382 shares of Common Stock |
| 26 May 2021 |
Form 3: Canaan Xi L.p., 10% owner and 1 other
Holds 3,245,869 shares of Common Stock |
| 26 May 2021 | Form 3: Ai Day 1 Llc, 10% owner and 3 others |
Loading...
